Please turn JavaScript on
biotechstrategyblog icon

biotechstrategyblog

Follow Biotechstrategyblog's news and updates in a matter of seconds! We will deliver any update via email, phone or you can read them from here on the site on your own news page.

You can even combine different feeds with the feed for Biotechstrategyblog.

Subscribing and unsubscribing is fast, easy and risk free.

The whole service is free of cost.

Biotechstrategyblog: Biotech Strategy Blog Cancer Conferences New Products

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  0.34 / day

Message History

Every so often, a small biotech comes along and produces just enough early clinical signal to make investors lean forward.…

Read full story
We all know tumours adapt in response to selective pressure for anti-cancer drugs. The next question is whether this adaptation…

Read full story
The interim data from the Akeso Bio run HARMONi-6 trial were first presented by Dr Shun Lu at ESMO last…

Read full story
In this latest article from ASCO, we continue our strategic read on emerging data from Chicago. We’re shifting focus to…

Read full story
ASCO’s opening day generated the usual cascade of superlatives, but the real story is more nuanced—and more useful for biotech…

Read full story